The National Institutes of Health (NIH) National Cancer Institute (NCI) recently awarded ICF (NASDAQ:ICFI), a global consulting and technology services provider, two re-compete blanket purchase agreements (BPA) to support the agency’s cancer content development, communications and web development efforts.
The BPAs, which were awarded in the third quarter, have a combined ceiling value of up to $70 million. Each has a term of five years which includes one 1-year base and four 1-year options. The first BPA is with the Office of Communications and Public Liaison (OCPL) and has a ceiling of $50 million; the second is with the Division of Cancer Control and Population Sciences (DCCPS) and has a ceiling of $20 million.
“ICF has deep institutional knowledge of NCI and its mission to advance scientific knowledge in the field through research, training and information sharing,” said Matthew Perry, senior vice president for ICF. “These awards highlight ICF’s strength in blending strong health subject matter expertise with innovative technology and communications support that provide NIH and HHS clients with high-quality, highly efficient solutions.”
The ICF team helps integrate, synthesize and communicate important health findings and translates complex scientific topics which supports the initiatives of researchers, scientists and health professionals. Unlocking these findings and disseminating them in a meaningful way is vital to enabling healthcare providers, patients and the public to make informed, even life-saving decisions.
To this work, ICF brings solid cancer expertise and experience in communications and informatics ranging from scientific and educational content development to database and web management to stakeholder engagement. The firm currently supports the Physician Data Query program, one of NCI’s most important tools in disseminating state-of-the-science information about cancer research, and digital engagement activities for an array of NCI initiatives including the Health Information National Trends survey and an initiative that focuses on cancer disparities and health equity research among American Indian and Alaska Native populations.
In addition, ICF supports multiple communications activities for NCI’s OCPL, including strategic communications, media training, digital strategy, social media monitoring and multicultural outreach, as well as the communications offices of four other NIH Institutes.
“NCI has long been a leader not just in research but in connecting stakeholders with data, information and digital interventions to support the nation’s fight against cancer,” said Kris Tremaine, senior vice president for ICF. “NCI continues to lead with these awards, amplifying research knowledge with combined data architecture, content strategy and health communications, combining different disciplines and digital approaches to deliver greater results at substantially lower cost.”
ICF (NASDAQ:ICFI) is a global consulting services company with approximately 7,500 full- and part-time employees, but we are not your typical consultants. At ICF, business analysts and policy specialists work together with digital strategists, data scientists and creatives. We combine unmatched industry expertise with cutting-edge engagement capabilities to help organizations solve their most complex challenges. Since 1969, public and private sector clients have worked with ICF to navigate change and shape the future. Learn more at icf.com.
Statements that are not historical facts and involve known and unknown risks and uncertainties are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. Such statements may concern our current expectations about our future results, plans, operations and prospects and involve certain risks, including those related to the government contracting industry generally; our particular business, including our dependence on contracts with U.S. federal government agencies; our ability to acquire and successfully integrate businesses; and the effects of the novel coronavirus disease (COVID-19) and related federal, state and local government actions and reactions on the health of our staff and that of our clients, the continuity of our and our clients' operations, our results of operations and our outlook. These and other factors that could cause our actual results to differ from those indicated in forward-looking statements THAT are included in the "Risk Factors" section of our securities filings with the Securities and Exchange Commission. The forward-looking statements included herein are only made as of the date hereof, and we specifically disclaim any obligation to update these statements in the future.